Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/08/17
End: 04/30/18
Due: 04/30/19
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 03/29/19
End: 12/29/19
Due: 12/29/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects | NCT03291418 | Antibe Therapeutics Inc. | user2@example.com | None | 2017-09-08 | 2018-04-30 | 2019-04-30 | - | - | 2025-07-14 |
| Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects | NCT03220633 | Antibe Therapeutics Inc. | user2@example.com | None | 2014-06-30 | 2014-12-31 | 2015-12-31 | - | - | 2025-07-14 |
| Efficacy and Safety of ATB-346 Versus Placebo in Osteoarthritis Patients | NCT03978208 | Antibe Therapeutics Inc. | user2@example.com | None | 2019-03-29 | 2019-12-29 | 2020-12-29 | - | - | 2025-07-14 |